Worldwide Healthcare Trust

Worldwide Healthcare Trust - November was a tumultuous month for healthcare equities. November factsheet 📰 November was a tumultuous month for #HealthcareEquities, primarily stemming from the outcomes and aftermath of the U.S. Presidential election. ❌ The bombshell announcement that President-Elect Trump was nominating outspoken healthcare critic Robert F. Kennedy Jr. for Secretary of Health and Human Services triggered an extreme sell-off in healthcare. ✅ Overall, all healthcare sub-sectors – save for Healthcare Services – contributed to relative #outperformance. ✅ Most resilient during the volatile month were #MedicalTechnology stocks. Here, both allocation and stock picking benefited performance. Boston Scientific, Intuitive Surgical, and Stryker comprised three of the top four contributors in November. ✅ Additional outperformance in the month came from Natera (outstanding quarter) and #LargeCapPharmaceuticals via the allocation effect as broad declines there benefited our underweight positioning. ❌ In terms of detractors, Healthcare Services provided the only relative headwind, mostly due to idiosyncratic reasons. We note the share price for UnitedHealth Group, which rose 10% post-election given the perception that a Republican administration is more friendly to heavily Medicare Advantage-exposed payors, like UnitedHealth Group. Given our material underweight positioning, this negatively impacted relative performance. These factors pre-dated the 4 December 2024 assassination of Brian Thompson, a senior executive for UnitedHealth Group, which precipitated a 10% fall in the share price in the subsequent four trading days after his shooting. You can watch the latest recording here 👉https://lnkd.in/eHrPHRA2 November factsheet: https://lnkd.in/e9XT5eUT Find out more here: https://lnkd.in/eRNN7UZ6 Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance.

How have the last three US administrations impacted the drug industry? ❓ During the #Obama and #Biden administrations, it was neutral/negative for the healthcare industry. In 2010, President Obama was introducing the Affordable Care Act , aka 'Obamacare', which enabled more patients to become eligible for Medicaid, however, a large part of the cost was absorbed by drug manufacturers. In 2022, President Biden introduced the Inflation Reduction Act (drug price negotiations). Drug price setting in Medicare has been industry altering; lowering revenue outlook, penalising small molecule development, and increasing industry costs whilst increased volumes remain to be seen. ✅ During the first Trump administration, it was a more favourable environment for healthcare because there were no major healthcare reforms on the horizon, with lower corporate tax rates leading to year-on-year earnings and record share buybacks. You can watch the latest recording here 👉https://lnkd.in/eHrPHRA2 October factsheet: https://lnkd.in/exe7H2EX Find out more here: https://lnkd.in/eRNN7UZ6 Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance.

Going into the #USelection, the market consensus by healthcare investors was that there would be a form of split congress; however, as we've seen, this wasn't the outcome. Instead, it was an unexpected #Republican sweep of the White House, Senate and House. The previous overhang concerning drug price reforms under the Democrats and the Inflation Reduction Act (#IRA), have now been removed. For us, it's clear that the Republican sweep is a big win for #healthcare stocks. You can watch the latest recording here 👉https://lnkd.in/eHrPHRA2 October factsheet: https://lnkd.in/exe7H2EX Find out more here: https://lnkd.in/eRNN7UZ6 Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance. *image as of 12 Nov. 2024

Does the recent upswing in performance for China’s stock market have further to run? Faith Glasgow weighs up reasons to be #bullish and #bearish. “More recently we have also discovered the incredible #innovation coming out of #China in this space, with drug discovery and development to rival and sometimes surpass Western counterparts,” says Sven Borho. Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance.

James Carthew looks at the outlook for healthcare following Donald Trumps US election victory. 'He (Sven Borho) thought that M&A activity within the sector would be easier to achieve, which would be good news for biotech as big pharma companies have to replace earnings from drugs that are scheduled to come off patent over the next few years. The manager also suggested that we could see some consolidation amongst the larger players.' #Healthcare #USElection #MergersAndAcquisitions Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance.

Worldwide Healthcare Trust - Trump win is highly positive for healthcare. October Factsheet 📰 In October, the NAV per share total return was -0.8%, the share price total return was -1.7% and the MSCI World Health Care Index was -0.8%, on a net total return, sterling adjusted basis ✅ Positive contribution came from three distinct sub-sectors. The largest and most important was Medical Technology, led by stellar quarterly reports by Boston Scientific and Intuitive Surgical, continuing a year long trend of innovation and business execution from these two companies. ❌ However, these gains were offset by detractors from three separate sub-sectors. The largest was Large Cap Pharmaceuticals where Eli Lilly and Company and Merck reported quarterly earnings that were mixed, and stock reactions were negative. ✅ Despite the mixed performance in October, we look forward to important political tailwinds post the U.S. Presidential #election that was concluded on 5 November 2024. ✅ This unexpected result is highly positive for healthcare, removing the chance of any further negative healthcare legislation from the Democrats whilst at the same time adding potential upside surprises from the much more industry-friendly Republicans. You can watch the latest recording here 👉https://lnkd.in/eHrPHRA2 October factsheet: https://lnkd.in/exe7H2EX Find out more here: https://lnkd.in/eRNN7UZ6 Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance.

'Worldwide Healthcare (WWH) trust believes the ‘malaise’ that has hung over the #biotech sector since the Covid pandemic has finally ‘evaporated’ as investors focus on company fundamentals again. Fund managers Sven Borho and Trevor Polischuk, Ph.D., M.B.A. noted that global healthcare stocks advanced and the MSCI World Health Care index hit an all-time high in dollar terms over the six months to the end of September.' 📈 Michelle McGagh writes in Citywire Investment Trust Insider. Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance.

On Tuesday, November 12th, we held our half-year fiscal shareholder update. Portfolio Managers, Sven Borho and Trevor Polischuk, Ph.D., M.B.A. provided an update on Worldwide Healthcare Trust’s strong year-to-date performance, discussing how the portfolio is positioned for the remainder of 2024 and beyond, whilst also highlighting any implications for the #healthcare sector, that may have arisen from the #USelection. You can watch the recording here 👉https://lnkd.in/eHrPHRA2 October factsheet: https://lnkd.in/exe7H2EX Find out more here: https://lnkd.in/eRNN7UZ6 Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance.

🎙️ Uncovering Trusts – Healthcare-focused trusts: A sector on the mend 🩹 In this episode, our healthcare analyst, Jyoti Prakash, CFA, and director of content, investment trusts Milosz Papst discuss Edison’s latest thematic research note on healthcare-focused investment companies as a way of gaining exposure to the sector while managing the downside risk. What to find out more? 🎧Listen to this episode on your podcast platform of choice 👇🏼 Apple Podcasts: https://lnkd.in/e-zhhPan Spotify: https://lnkd.in/dEi6ep6e Google Podcasts: https://lnkd.in/dTDVWc3s Zencastr: https://lnkd.in/dbAz8wJH YouTube: https://lnkd.in/eQGCKmyj 📑Read the full report here: https://lnkd.in/e_pBURxP 🎥 Register for our upcoming webinar on 21 November 2024 at 3 PM GMT to learn key findings from the report: https://lnkd.in/dKb8H_Kr BB Biotech #BION BioPharma Credit PLC #BPCR Bellevue Healthcare Trust #BBH THE BIOTECH GROWTH TRUST PLC #BIOG HBM Healthcare Investments AG #HBMN International Biotechnology Trust Plc #IBT IP Group plc #IPO POLAR CAPITAL GLOBAL HEALTHCARE GROWTH AND INCOME TRUST PLC #PCGH RTW Biotech Opportunities #RTW Syncona Limited #SYNC Worldwide Healthcare Trust #WWH Xlife Sciences AG #XLS

The most recent Edison Group report, featuring Worldwide Healthcare Trust, examining the current state and prospects of healthcare-focused investment trusts, highlighting the sector’s resilience and potential for recovery following the #COVID-19 pandemic and subsequent market corrections. 'Robust business models rarely go out of favour, though temporary setbacks are not unheard of. Driven by megatrends and with #innovation as its backbone, the #healthcare sector offers strong business models, with varied opportunities for diverse risk appetites.' Investments involve risks. The value of investments and income derived from them may go down as well as up and you may not receive back all the money which you invest. Past performance is no guarantee of future performance.